๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Metabolic studies in diabetics on tolbutamide. Comparison of a single dose with a divided dose regimen

โœ Scribed by A. I. Vinik; W. P. U. Jackson; P. Keller; N. Marine


Publisher
Springer
Year
1968
Tongue
English
Weight
716 KB
Volume
4
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Doxorubicin cardiotoxicity in children:
โœ Ewer, Michael S.; Jaffe, Norman; Ried, Hubert; Zietz, Hallie A.; Benjamin, Rober ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 61 KB ๐Ÿ‘ 2 views

Background. Doxorubicin cardiotoxicity remains a serious problem in children with malignancy. The present study was undertaken to determine if the administration of consecutive divided daily doses of doxorubicin would significantly reduce the likelihood of cardiotoxicity in children compared with a

A novel three-dose regimen of daclizumab
โœ W. Kenneth Washburn; Lewis W. Teperman; Thomas G. Heffron; David D. Douglas; Ste ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 161 KB

This study evaluated the pharmacokinetics and pharmacodynamics of a novel 3-dose regimen of daclizumab in de novo hepatitis C liver transplant recipients. In 30 of 156 recipients receiving daclizumab, mycophenolate mofetil, tacrolimus, and no steroids (Arm 3 of Hep C 3 Liver Study), daclizumab (2, 2

Effect of a single infusion of alendrona
โœ R. Rizzoli; B. Buchs; J.-P. Bonjour ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 789 KB

Among aminohydroxybisphosphonate derivatives, alendronate (3-amino-I -hydroxybutylidene-I, I -bisphosphonate) has proved efficacious in diseases with increased bone resorption. However, the effective dose in the treatment of malignant hypercalcaemia is not clearly established. In 2 randomized studie